At last! Someone looking to address the serious lack of funding into Altzheimers - let's hope as much as possible goes towards research into preventative measures and protecting the brain rather than just all gobbled up by drug companies looking for a silver bullet that doesn't exist.
Neil Hunt, Chief Executive, Alzheimer's Society said,
The topics that may be considered for funding in the areas of cause, cure, care and prevention include:
• Epidemiology of all forms of dementia
• The causes of dementia and mechanism of disease progression
• The causal relationship between genetics and lifestyle factors predisposing people to dementia
• Prevention, diagnosis and treatment of dementia
• Slowing the progress of dementia
• Developing (non-embryonic) stem cell therapies with translational benefits for people with dementia
• Evidence for dietary supplements or complementary therapies as an alternative to drugs
• Improving Quality of life for people with dementia in their own homes or care homes
• How to best train staff in all health sectors, at all levels, in communicating with, understanding the needs of, and caring for people with dementia
• Management of anxiety, agitation and other behavioral symptoms, without the use of antipsychotic drugs
• The impact of acute hospitalization of people with dementia
For more information contact:
Brett Lowther
BUPA Corporate Affairs
Tel: +44 (0)20 7656 2638
Email: lowtherb@bupa.com
Notes:
• One in three people over 65 will die with dementia
• Alzheimer’s Society research shows that 700,000 people in the UK have a form of dementia, more than half have Alzheimer’s disease. In less than 20 years nearly a million people will be living with dementia. This will soar to 1.7 million people by 2051.








